Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Myopic implantable collamer lens of -20.00 D after 5-year follow-up

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Presented Poster Session: Phakic IOLs

Session Date/Time: Monday 07/09/2015 | 09:30-10:50

Paper Time: 10:10

Venue: Poster Village: Pod 2

First Author: : C.Perez-Vives SPAIN

Co Author(s): :    C. Lisa   B. Baamonde   R. Montes-Mico   J. Alfonso     

Abstract Details

Purpose:

To evaluate refractive and visual outcomes and complications associated with Implantable Collamer Lens (ICL) implantation to correct high myopia.

Setting:

Fernández-Vega Ophthalmological Institute, Oviedo, Spain.

Methods:

Retrospective observational case series study involved 61 eyes of 45 patients, of which 28 (62.2%) were women and 17 men (37.7%). The mean age of the patients at the time of surgery was 35.08 ± 7.08 years. Uncorrected (UCVA) and best-corrected distance visual acuity (BCVA), refraction, vault and adverse effects were evaluated after five years ICMV4 ICL model implantation.

Results:

Mean spherical equivalent (SE) dropped from -18.32±2.37 diopters (D) preoperatively to -0.88±0.52D 5-years postoperatively. The mean Snellen decimal BCVA and UCVA were 0.73±0.23 and 0.55±0.26, respectively. More than 50% of eyes achieved 20/25 or better BCVA postoperatively. The safety index was 1.26±0.32. Forty eyes (65.5%) had UCVA of 20/40 or better postoperatively. The efficacy index was 0.99±0.42. Mean central vault was 475.28±216.38µm postoperatively. No eyes showed central contact between ICL and crystalline lens. Nevertheless, 10 eyes showed peripheral contact; with a central vault between 150 and 260µm. Two eyes developed anterior subcapsular cataract, although just one eye required cataract surgery.

Conclusions:

These outcomes showed that ICMV4 ICL is a safe, predictable and effective procedure to correct high levels of myopia over 5-years postoperatively. Furthermore, we suggested a minimum central vault greater than 260 µm to avoid the anterior subcapsular development in patients implanted with an ICL of -20.00 D.

Financial Interest:

NONE

Back to previous